Acitretin, a psoriasis medication, is another extensively studied repurposed drug for AD capable of inducing ADAM10 activity in vivo and clinically (Tippmann et al., 2009; Endres et al., 2014; Brummer et al., 2019; Rosales Jubal et al., 2021). This evidence concerns the gene ADAM10 and Alzheimer disease.